Expert Recommendations on Community-based Management of Women with Abnormal Cervical Cancer Screening Test Results

doi:10.12114/j.issn.1007-9572.2021.00.531

Abstract

Abstract: Chinese Medical Doctor Association（CMDA）'s General Practitioners Sub-association，the Primary Care Branch of Beijing Institute of Obstetrics & Gynecology To reduce the incidence of cervical cancer via standardizing the prevention and control of cervical cancer in primary care，and the management and follow-up of women with abnormal cervical cancer screening test results and those with treatment for cervical lesions，China General Practitioner Association，Chinese Medical Doctor Association，and Community and Primary Care Branch，Beijing Institute of Obstetrics & Gynecology，invited relevant experts to develop the Expert Recommendations on Community-based Management of Women with Abnormal Cervical Cancer Screening Test Results，on the basis of reviewing guidelines on cervical cancer screening and managing women with abnormal cervical cancer screening test results，mainly involving cervical cancer prevention and control issues in primary care，such as creating personal health records，health education，classified management and bi-directional referrals.The recommendations will be vital to the improvement of community-based management of women with abnormal cervical cancer screening test results.

Key words: Early detection of cancer；Women's health services；Uterine cervical neoplasms；Uterine cervical cancers；Hospitals, community；Community health services

摘要：

为规范基层医疗机构子宫颈癌防控工作，对子宫颈癌筛查结果异常人群及宫颈病变治疗后人群规范管理与随访，最终降低子宫颈癌发病率，中国医师协会全科医师分会与北京妇产学会社区与基层分会组织有关专家，针对基层医疗机构子宫颈癌防控面临的问题，参照国内国际子宫颈癌筛查及异常管理相关指南，制定《子宫颈癌筛查结果异常人群社区管理专家建议》，主要包括建立健康档案、健康教育、分类管理及上下转诊等内容。该专家建议的发布对提高基层医疗机构子宫颈癌筛查结果异常人群社区管理水平有重要意义。

关键词: 癌症早期检测；妇女卫生保健服务；宫颈肿瘤；子宫颈癌；医院, 社区；社区卫生服务

Chinese Medical Doctor Association（CMDA）'s General Practitioners Sub-association,the Primary Care Branch of Beijing Institute of Obstetrics & Gynecology.Expert recommendations on community-based manag. Expert Recommendations on Community-based Management of Women with Abnormal Cervical Cancer Screening Test Results　[J]. Chinese General Practice, 2021, 24(17): 2117-2121. DOI: 10.12114/j.issn.1007-9572.2021.00.531.
中国医师协会全科医师分会,北京妇产学会社区与基层分会. 子宫颈癌筛查结果异常人群社区管理专家建议[J]. 中国全科医学, 2021, 24(17): 2117-2121. DOI: 10.12114/j.issn.1007-9572.2021.00.531.

References

［1］PAHO.WHO Director-General calls for all countries to take action to help end the suffering caused by cervical cancer［EB/OL］.［2021-02-15］.https：//www.paho.org/hq/index.php?option=com_content&view=article&id=14358：who-director-general-calls-for-all-countries-to-take-action-to-help-end-the-suffering-caused-by-cervical-cancer&Itemid=40591&lang=en.
［2］孙静，张新宇，于红.妇女对宫颈癌筛查的认知、态度和行为状况调查及相关因素分析［J］.护理研究，2011，25（25）：2279-2281．DOI：10.3969/j.issn.1009-6493.2011.25.012.
SUN J，ZHANG X Y，YU H.Investigation on status quo of cognition，attitude and behavior of women toward cervical cancer screening and analysis of its related factors［J］.Chin Nurs Res，2011，25（25）：2279-2281．DOI：10.3969/j.issn.1009-6493.2011.25.012.
［3］魏丽惠，吴久玲.子宫颈癌检查质量保障及质量控制指南［M］.北京：人民卫生出版社，2015：16-17.
［4］徐帅师，聂文佳，张咏梅.宫颈人乳头瘤病毒感染治疗方法研究进展［J/OL］.病毒学报：1-8.［2021-03-15］.https：//doi.org/10.13242/j.cnki.bingduxuebao.003903.
［5］赵健，廖秦平，谢红，等．保妇康栓治疗人乳头瘤病毒感染的临床观察［J］.实用妇产科杂志，2015，31（1）：45-48.
ZHAO J，LIAO Q P，XIE H，et al．A observational analysis of baofukang suppository for treatment of HPV infection［J］.J Pract Obstet Gynecol，2015，31（1）：45-48.
［6］中华中医药学会.中医妇科常见病诊疗指南［M］.北京：中国中医药出版社，2012.
［7］中国优生科学协会阴道镜和宫颈病理学分会专家委员会.中国子宫颈癌筛查及异常管理相关问题专家共识（一）［J］.中国妇产科临床杂志，2017，18（2）：190-192．DOI：10.13390/j.issn.1672-1861.2017.02.032.https：//d.wanfangdata.com.cn/periodical/ChlQZXJpb2RpY2FsQ0hJTmV3UzIwMjEwMzAyEhJ6Z2Zja2xjenoyMDE3MDIwMzIaCGt6YW40cXpj.
［8］MASSAD L S，EINSTEIN M H，HUH W K，et al．2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors［J］.Obstet Gynecol，2013，121（4）：829-846．DOI：10.1097/AOG.0b013e3182883a34.
［9］中国优生科学协会阴道镜和宫颈病理学分会（CSCCP）专家委员会 .中国子宫颈癌筛查及异常管理相关问题专家共识（二）［J］.中国妇产科临床杂志，2017，18（3）：286-288．DOI：10.13390/j.issn.1672-1861.2017.03.041.https：//d.wanfangdata.com.cn/periodical/ChlQZXJpb2RpY2FsQ0hJTmV3UzIwMjEwMzAyEhJ6Z2Zja2xjenoyMDE3MDMwNDEaCDhwaGRuaDZp.
［10］EGEMEN D，CHEUNG L C，CHEN X J，et al．Risk estimates supporting the 2019 ASCCP risk-based management consensus guidelines［J］.J Low Genit Tract Dis，2020，24（2）：132-143．DOI：10.1097/LGT.0000000000000529.
［11］PERKINS R B，GUIDO R S，CASTLE P E，et al．2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors［J］. J Low Genit Tract Dis，2020，24（2）：102-131．DOI：10.1097/LGT.0000000000000525.
［12］MASSAD L S，EINSTEIN M H，HUH W K，et al．2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors［J］.Obstet Gynecol，2013，121（4）：829-846．DOI：10.1097/AOG.0b013e3182883a34.
［13］FUKUCHI E，FETTERMAN B，POITRAS N，et al．Risk of cervical precancer and cancer in women with cervical intraepithelial neoplasia grade 1 on endocervical curettage［J］.J Low Genit Tract Dis，2013，17（3）：255-260．DOI：10.1097/lgt.0b013e31826ca4d9.
［14］LEUNG S O A，VITONIS A，FELDMAN S.Yield of loop electrosurgical excision procedure（LEEP）among patients with and without known high-grade cervical dysplasia［J］.Gynecol Oncol，2020，159：194．DOI：10.1016/j.ygyno.2020.05.303.
［15］ARBYN M，RONCO G，ANTTILA A，et al．Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer［J］.Vaccine，2012，30（Suppl 5）：F88-99．DOI：10.1016/j.vaccine.2012.06.095.
［16］TEOH D，MUSA F，SALANI R，et al．Diagnosis and management of adenocarcinoma in situ：a society of gynecologic oncology evidence-based review and recommendations［J］.Obstet Gynecol，2020，135（4）：869-878．DOI：10.1097/AOG.0000000000003761.